Forum Discussion

Marianne_BCNA's avatar
Marianne_BCNA
Member
7 years ago

Two steps forward, one step back – news on access to CDKs in second line treatment

Hello everyone, BCNA has an update on access to CDKs as second line treatment. Pfizer have this week advised BCNA about a new capped access program for the CDK inhibitor palbociclib (lbrance) wh...
metastatic-breast-cancer
palbociclib
brightspace's avatar
brightspace
Member
7 years ago
Copy Link
Thankyou Marinne
Wonderful to know that some access progress has been achieved for longer term met patients.
All the best to everyone who are  able to now afford and start 
Bright in hope